![Elin Trampe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Elin Trampe is currently the Chief Executive Officer at Dicot Pharma AB since 2022.
Formerly, Ms. Trampe was the Chief Technology Officer at Vivesto AB. Education includes a graduate degree from the University of Linköping.
Postes actifs de Elin Trampe
| Sociétés | Poste | Début |
|---|---|---|
| DICOT PHARMA AB | Directeur Général | 01/04/2022 |
Anciens postes connus de Elin Trampe
| Sociétés | Poste | Fin |
|---|---|---|
| VIVESTO AB | Directeur Technique/Scientifique/R&D | - |
Formation de Elin Trampe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Dicot Pharma AB
 Dicot Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs to treat erectile failure | Health Technology |
